References
- Chan, K. H., Tse, C. T., Chung, C. P., Lee, R. L., Kwan, J. S., Ho, P. W., & Ho, J. W. (2011). Brain involvement in neuromyelitis optica spectrum disorders. Archives of Neurology, 68, 1432–1439. https://doi.org/10.1001/archneurol.2011.249
- Jurynczyk, M., Geraldes, R., Probert, F., Woodhall, M. R., Waters, P., Tackley, G., DeLuca, G., Chandratre, S., Leite, M. I., Vincent, A., & Palace, J. (2017). Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain, 14, 617–627. https://doi.org/10.1093/brain/aww350
- Kim, H. J., Paul, F., Lana-Peixoto, M. A., Tenembaum, S., Asgari, N., Palace, J., Klawiter, E. C., Sato, D. K., de Seze, J., Wuerfel, J., Banwell, B. L., Villoslada, P., Saiz, A., Fujihara, K., & Kim, S. H., & Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository. (2015). MRI characteristics of neuromyelitis optica spectrum disorder: An international update. Neurology, 84, 1165–1173. https://doi.org/10.1212/WNL.0000000000001367
- Kim, J. E., Kim, S. M., Ahn, S. W., Lim, B. C., Chae, J. H., Hong, Y. H., Park, K. S., Sung, J. J., & Lee, K. W. (2011). Brain abnormalities in neuromyelitis optica. Journal of the Neurological Sciences, 302, 43–48. https://doi.org/10.1016/j.jns.2010.12.001
- Li, Y., Xie, P., Lv, F., Mu, J., Li, Q., Yang, Q., Hu, M., Tang, H., & Yi, J. (2008). Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurologica Scandinavica, 118, 218–225. https://doi.org/10.1111/j.1600-0404.2008.01012.x
- Liao, M. F., Chang, K. H., Lyu, R. K., Huang, C. C., Chang, H. S., Wu, Y. R., Chen, C. M., Chu, C. C., Kuo, H. C., & Ro, L. S. (2014). Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in taiwanese patients. BMC Neurology, 14, 218. https://doi.org/10.1186/s12883-014-0218-8
- Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006). Brain abnormalities in neuromyelitis optica. Archives of Neurology, 63, 390–396. https://doi.org/10.1001/archneur.63.3.390
- Sechi, E., Addis, A., Batzu, L., Mariotto, S., Ferrari, S., Conti, M., & Sechi, G. (2018). Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings. Multiple Sclerosis (Houndmills, Basingstoke, England), 24, 685–688. https://doi.org/10.1177/1352458517721661
- Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., De Seze, J., Fujihara, K., Greenberg, B., Jacob, A., Jarius, S., Lana-Peixoto, M., Levy, M., Simon, J. H., Tenembaum, S., Traboulsee, A. L., Waters, P., Wellik, K. E., & Weinshenker, B. G., & International Panel for NMO Diagnosis. (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 85, 177–189. https://doi.org/10.1212/WNL.0000000000001729
- Zhang, L., Wu, A., Zhang, B., Chen, S., Men, X., Lin, Y., & Lu, Z. (2014). Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica. Multiple Sclerosis (Houndmills, Basingstoke, England), 20, 418–423. https://doi.org/10.1177/1352458513499420